The higher carbapenem resistance observed in 2024 warrants continued surveillance, while interpretation of temporal changes should account for multiple-testing correction and breakpoint revisions during the study period.
Abstract
Background: Klebsiella pneumoniae is a leading cause of multidrug-resistant Gram-negative infections worldwide, with carbapenem resistance posing a major therapeutic challenge. Continuous surveillance of antimicrobial resistance is essential to guide empirical therapy, optimize antimicrobial stewardship, and inform infection prevention strategies. Methods: We conducted a retrospective study of 2014 calendar-year patient-level non-duplicate K. pneumoniae isolates collected between 2020 and 2024 at a tertiary care hospital in Riyadh, Saudi Arabia. Only the first isolate of each species per patient per calendar year was included, regardless of specimen source or susceptibility profile. Antimicrobial susceptibility was assessed against 12 antibiotics. Temporal resistance trends were evaluated, and multivariable logistic regression assessed the association between patient setting and resistance, adjusting for study year and specimen source. Results: A total of 415 isolates (20.6%) exhibited an extended-spectrum beta-lactamase (ESBL) phenotype and 55 isolates (2.7%) met the study definition of CRKP. Co-trimoxazole showed a significant decreasing temporal trend after Benjamini–Hochberg correction. Imipenem and meropenem resistance increased from 2.3% in 2020 to 5.3% in 2024; their raw trend p-values were significant, but neither remained significant after multiple-testing correction (BH-adjusted p = 0.055). Inpatient isolates had higher adjusted odds of resistance for all 12 antibiotics. Conclusions: Resistance to several beta-lactams and fluoroquinolones remained substantial. The higher carbapenem resistance observed in 2024 warrants continued surveillance, while interpretation of temporal changes should account for multiple-testing correction and breakpoint revisions during the study period.
Background Pseudomonas aeruginosa is a major cause of healthcare-associated infections and is increasingly associated with antimicrobial resistance. Continuous local surveillance is essential to monitor evolving resistance patterns and inform empirical antimicrobial therapy and antimicrobial stewardship. Methods This r...
W. A. Alghamdi, K. Orayj, Ahmed R. N. Ibrahim et al.· Frontiers in Antibiotics· 0 citations
At this centre, carbapenem resistance in Gram-negative HAI is endemic, could not be predicted from the routinely recorded characteristics examined, and exceeds European surveillance figures only among the Enterobacterales.
Răzvan Roșca, Calin Muntean, M. Frandeș et al.· Antibiotics· 0 citations
These findings demonstrate a critical burden of XDR-GNB and the presence of multiple carbapenemases (NDM, IMP, KPC and VIM) associated with clinically relevant high-risk lineages associated with clinically relevant high-risk lineages.
Eddie Angles-Yanqui, Katherine Yauri-Condor, J. Velásquez-Pomar et al.· JAC-Antimicrobial Resistance· 0 citations
The institution-specific resistance patterns generated in this study support a data-driven recalibration of empirical antimicrobial therapy, while reinforcing the need for sustained antimicrobial stewardship and strengthened infection prevention measures.
Charmi Mangal, Payal Khant, Kairavi Passwala et al.· Journal of Clinical and Diag...· 0 citations
Background: Klebsiella pneumoniae is an important opportunistic pathogen increasingly associated with multidrug resistance and persistent healthcare-associated infections. Biofilm formation may enhance bacterial survival, reduce antimicrobial susceptibility, and contribute to treatment failure. This study evaluated the...
Manaswini Das, Sobha Nagalla, P. S. Swaroop et al.· International Journal of Dru...· 0 citations
Carapenem resistance was particularly concerning among non-fermenting Gram-negative bacteria, especially A. baumannii and P. aeruginosa, and the findings support stronger antimicrobial stewardship, infection-prevention measures, and laboratory-based surveillance.
Matheus Sebastian da Silva, T. Fonseca, A. J. Reis et al.· Indian Journal of Medical Mi...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.